FindTrial
Sign In

A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)

SARS-CoV-2 Infection on Myocardial Injury and Prognosis: a Multicenter, Long- term Follow-up and Registration Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030482
Enrollment
Unknown
Registered
2020-03-03
Start date
2020-03-06
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:NA

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) All confirmed and diagnosed SARS-CoV-2 infection patients (including the clinical diagnosis case of the New Coronavirus Pneumonia HUBEI) (Fifth Edition) (2) Voluntarily agree to enter the trial and sign the written informed consent.

Exclusion criteria

Exclusion criteria: Patients not suitable for study judged by researchers.

Design outcomes

Primary

MeasureTime frame
Cardiac injury;Death in hospital and/or Endotracheal Intubation Deaths during hospitalization;Admitted to the ICU;Composite end points of cardiovascular events( nonfatal heart failure, nonfatal myocardial infarction, nonfatal stroke or cardiovascular death);Stroke;Heart failure;Myocardial infarction;Other cardiovascular health related endpoints;—

Countries

China

Contacts

Public ContactYong Huo

Peking University First Hospital

drhuoyong@163.com+86 13901333060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026